Factors on survival for patients of EGFR mutation advanced lung adenocarcinoma with EGFR-TKIs combined with radiotherapy: Real-world data from single center.
第一作者机构:[1]Hebei Med Univ, Hosp 4, Dept Radiat Oncol, Shijiazhuang, Hebei, Peoples R China[2]Hebei Prov Tumor Hosp, Shijiazhuang, Hebei, Peoples R China[3]Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China[4]Hebei Med Univ, Hosp 4, Dept Radiat Oncol, Shijiazhuang, Hebei, Peoples R China[5]Hebei Prov Tumor Hosp, Shijiazhuang, Hebei, Peoples R China[6]Hebei Tumor Hosp, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
Wang Yuxiang,Yu Wenjian,Shi Jian,et al.Factors on survival for patients of EGFR mutation advanced lung adenocarcinoma with EGFR-TKIs combined with radiotherapy: Real-world data from single center.[J].JOURNAL OF CLINICAL ONCOLOGY.2021,39(15):doi:10.1200/JCO.2021.39.15_suppl.e21126.
APA:
Wang, Yuxiang,Yu, Wenjian,Shi, Jian,Jiang, Nan,Wang, Zhoufan...&Song, Meng.(2021).Factors on survival for patients of EGFR mutation advanced lung adenocarcinoma with EGFR-TKIs combined with radiotherapy: Real-world data from single center..JOURNAL OF CLINICAL ONCOLOGY,39,(15)
MLA:
Wang, Yuxiang,et al."Factors on survival for patients of EGFR mutation advanced lung adenocarcinoma with EGFR-TKIs combined with radiotherapy: Real-world data from single center.".JOURNAL OF CLINICAL ONCOLOGY 39..15(2021)